|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| C07D 487/04 | (2013.01) |
| (11) | Patento numeris | 3938368 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20717027.5 |
| Europos patento paraiškos padavimo data | 2020-03-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2022-01-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-06-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2020/021648 |
| Data | 2020-03-09 |
| (87) | Numeris | WO 2020/185648 |
| Data | 2020-09-17 |
| (30) | Numeris | Data | Šalis |
| 201962816402 P | 2019-03-11 | US |
| (72) |
UDDIN, Akm, Nasir , US
DALI, Mandar, Vasant , US
VAZE, Onkar, Shripad , US
|
| (73) |
PTC Therapeutics, Inc. ,
100 Corporate Court,, South Plainfield, NJ 07080,
US
|
| (54) | COMPOUND FORM HAVING ENHANCED BIOAVAILABILITY AND FORMULATIONS THEREOF |
| COMPOUND FORM HAVING ENHANCED BIOAVAILABILITY AND FORMULATIONS THEREOF |